Document Detail


Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
MedLine Citation:
PMID:  20299787     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Stroke prevention with oral anticoagulation is effective in patients with atrial fibrillation. An additional beneficial effect of oral anticoagulation prior to the event on stroke severity and prognosis was suggested in ischemic strokes. We tested whether this benefit is preserved after inclusion of hemorrhagic strokes and adjustment for prestroke living conditions. METHODS: Data were used from a prospective hospital-based intervention trial evaluating quality of care and outcome in ten district hospitals. All ischemic and hemorrhagic stroke patients with atrial fibrillation were included. We analyzed separate multivariable regression models to identify factors associated with prescription of oral anticoagulation before stroke and to investigate the independent effect of anticoagulation on admission stroke severity, 3-month mortality and functional outcome. RESULTS: The analysis comprised 804 (718 ischemic, 86 hemorrhagic) stroke patients admitted between July 2003 and March 2005. Males, patients aged 65-84, living independently, with diabetes, previous cerebrovascular event or additional high cardioembolic risks were more likely to receive oral anticoagulation before admission. Admission international normalized ratio (INR) between 2 and 3 (OR 0.35, 95% CI: 0.17-0.71) or higher (OR 0.32, 95% CI: 0.11-0.92) was associated with less severe strokes (including hemorrhagic strokes) compared with INR <2. Anticoagulation was associated with decreased risk of death and poor functional outcome (modified Rankin Scale >3) at 3 months (OR 0.54, 95% CI: 0.36-0.84, and OR 0.70, 95% CI: 0.47-1.06). After adjustment for stroke severity, anticoagulation had no additional effect on mortality and functional outcome. CONCLUSIONS: The beneficial effect of prestroke anticoagulation on stroke outcome related to the reduced stroke severity is not offset by adverse effects in hemorrhagic stokes.
Authors:
Heinrich J Audebert; Berit Schenk; Johannes Schenkel; Peter U Heuschmann
Related Documents :
23677267 - An experience of laparoscopic sleeve gastrectomy in obese, morbidly obese, and super mo...
18062447 - A case-control study of tissue plasminogen activator for acute ischemic stroke.
6602597 - Life expectancy and late stroke following carotid endarterectomy.
18562077 - The medical priority dispatch system's ability to predict cardiac arrest outcomes and h...
18207307 - Us-guided percutaneous radiofrequency thermal ablation for the treatment of solid benig...
22435787 - The impact of hospitalists on length of stay and costs: systematic review and meta-anal...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2010-03-19
Journal Detail:
Title:  Cerebrovascular diseases (Basel, Switzerland)     Volume:  29     ISSN:  1421-9786     ISO Abbreviation:  Cerebrovasc. Dis.     Publication Date:  2010  
Date Detail:
Created Date:  2010-04-28     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100851     Medline TA:  Cerebrovasc Dis     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  476-83     Citation Subset:  IM    
Copyright Information:
Copyright 2010 S. Karger AG, Basel.
Affiliation:
Center for Stroke Research, Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany. heinrich.audebert@charite.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Aged, 80 and over
Anticoagulants / administration & dosage,  therapeutic use*
Atrial Fibrillation / complications*
Case-Control Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multivariate Analysis
Prognosis
Prospective Studies
Retrospective Studies
Severity of Illness Index*
Stroke / diagnosis,  prevention & control*
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fibro-Fatty Volume of Culprit Lesions in Virtual Histology Intravascular Ultrasound Is Associated wi...
Next Document:  Mean Platelet Volume in the Early Phase of Acute Ischemic Stroke Is Not Associated with Severity or ...